Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model

European Journal of Pharmacology

Volumn 699, Issue 1-3, 2013, Pages 81-87

  Hirata, Yoichiro ^a,b   Kurobe, Hirotsugu ^a   Uematsu, Etsuko ^a   Yagi, Shusuke ^a   Soeki, Takeshi ^a   Yamada, Hirotsugu ^a   Fukuda, Daiju ^a   Shimabukuro, Michio ^a   Nakayama, Mizuho ^c   Matsumoto, Kunio ^c   Sakai, Yoshiki ^d   Kitagawa, Tetsuya ^a   Sata, Masataka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Dilated cardiomyopathy; Experimental autoimmune myocarditis; Heart failure; HGF; Prostacyclin

Indexed keywords

7,8 DIHYDRO 5 [2 [[ALPHA (3 PYRIDYL)BENZYLIDENE]AMINOOXY]ETHYL] 1 NAPHTHYLOXYACETIC ACID; BRAIN NATRIURETIC PEPTIDE; CYTOKINE ANTIBODY; MYOSIN; SCATTER FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE MYOCARDITIS; BRAIN LEVEL; CAPILLARY DENSITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFICACY; ECHOCARDIOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; HEART FUNCTION; HEART MUSCLE; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; AUTOIMMUNE DISEASES; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HEMODYNAMICS; MALE; MYOCARDITIS; MYOSINS; NATRIURETIC PEPTIDE, BRAIN; PYRIDINES; RATS; RATS, INBRED LEW; STEM CELLS;

EID: 84871890689     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.045     Document Type: Article

References (31)

1. N. Antonio, R. Fernandes, N. Rodriguez-Losada, M.F. Jimenez-Navarro, A. Paiva, E. de Teresa Galvan, L. Goncalves, C.F. RibeiroL., and A. Providencia Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs Eur. J. Clin. Pharmacol. 66 2010 219 230
2. K.R. Chien Genomic circuits and the integrative biology of cardiac diseases Nature 407 2000 227 232
3. K. Fuse, M. Kodama, M. Ito, Y. Okura, K. Kato, H. Hanawa, S. Aoki, and Y. Aizawa Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats Clin. Exp. Immunol. 134 2003 403 408
4. K. Hayashi, T. Nagamatsu, T. Oka, and Y. Suzuki Modulation of anti-glomerular basement membrane nephritis in rats by ONO-1301, a non-prostanoid prostaglandin I2 mimetic compound with inhibitory activity against thromboxane A2 synthase Jpn. J. Pharmacol. 73 1997 73 82
5. Y. Hirata, M. Shimabukuro, E. Uematsu, T. Soeki, H. Yamada, Y. Sakai, M. Nakayama, K. Matsumoto, T. Igarashi, and M. Sata A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury Eur. J. Pharmacol. 674 2012 352 358
6. Y. Hirata, T. Soeki, M. Akaike, Y. Sakai, T. Igarashi, and M. Sata Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters Biomed. Pharmacother. 63 2009 781 786
7. J.J. Hunter, and K.R. Chien Signaling pathways for cardiac hypertrophy and failure N. Engl. J. Med. 341 1999 1276 1283
8. H. Imawaka, and Y. Sugiyama Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist J. Pharmacol. Exp. Ther. 284 1998 949 957
9. K. Ishizawa, H. Kubo, M. Yamada, S. Kobayashi, T. Suzuki, S. Mizuno, T. Nakamura, and H. Sasaki Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells Biochem. Biophys. Res. Commun. 324 2004 276 280
10. H. Iwata, K. Nakamura, M. Sumi, M. Ninomiya, Y. Sakai, Y. Hirata, M. Akaike, T. Igarashi, S. Takamoto, R. Nagai, and M. Sata Local delivery of synthetic prostacycline agonist augments collateral growth and improves cardiac function in a swine chronic cardiac ischemia model Life Sci. 85 2009 255 261
11. N. Jovanvic, M. Pavlovic, V. Mircevski, Q. Du, and A. Jovanovic An unexpected negative inotropic effect of prostaglandin F2α in the rat heart Prostaglandins Other Lipid Mediat. 80 2006 110 119
12. G. Johnson 3rd, L.E. Furlan, N. Aoki, and A.M. Lefer Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats Circ. Res. 66 1990 1362 1370
13. J. Kawabe, K. Yuhki, M. Okada, T. Kanno, A. Yamauchi, N. Tashiro, T. Sasaki, S. Okumura, N. Nakagawa, Y. Aburakawa, N. Takehara, T. Fujino, N. Hasebe, S. Narumiya, and F. Ushikubi Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling Arterioscler. Thromb. Vasc. Biol. 30 2010 464 470
14. M. Kodama, H. Hanawa, M. Saeki, H. Hosono, T. Inomata, K. Suzuki, and A. Shibata Rat dilated cardiomyopathy after autoimmune giant cell myocarditis Circ. Res. 75 1994 278 284
15. K. Matsumoto, H. Okazaki, and T. Nakamura Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration J. Biochem. 117 1995 458 464
16. S. Mizuno, K. Matsumoto, and T. Nakamura Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy Kidney Int. 59 2001 1304 1314
17. S. Murakami, N. Nagaya, T. Itoh, M. Kataoka, T. Iwase, T. Horio, Y. Miyahara, Y. Sakai, K. Kangawa, and H. Kimura Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice Am. J. Physiol. Lung. Cell. Mol. Physiol. 290 2006 L59 65
18. K. Nakamura, M. Sata, H. Iwata, Y. Sakai, Y. Hirata, K. Kugiyama, and R. Nagai A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart Clin. Sci. (Lond) 112 2007 607 616
19. T. Nakamura, K. Matsumoto, S. Mizuno, Y. Sawa, and H. Matsuda Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2131 2139
20. T. Nakamura, T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, and S. Shimizu Molecular cloning and expression of human hepatocyte growth factor Nature 342 1989 440 443
21. T. Nakamura, T. Torimura, M. Sakamoto, O. Hashimoto, E. Taniguchi, K. Inoue, R. Sakata, R. Kumashiro, T. Murohara, T. Ueno, and M. Sata Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model Gastroenterology 133 2007 91 107 e101
22. H. Ohmichi, U. Koshimizu, K. Matsumoto, and T. Nakamura Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development Development 125 1998 1315 1324
23. S.S. Palaniyandi, K. Watanabe, M. Ma, H. Tachikawa, M. Kodama, and Y. Aizawa Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats Eur. J. Immunol. 34 2004 3508 3515
24. J.A. Rudd, Y. Qian, K.K. Tsui, and R.L. Jones Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon Br. J. Pharmacol. 129 2000 782 790
25. A. Sakamoto, K. Ono, M. Abe, G. Jasmin, T. Eki, Y. Murakami, T. Masaki, T. Toyo-oka, and F. Hanaoka Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex Proc. Nat. Acad. Sci. U. S. A. 94 1997 13873 13878
26. B. Swynghedauw Molecular mechanisms of myocardial remodeling Physiol. Rev. 79 1999 215 262
27. K. Tashiro, M. Hagiya, T. Nishizawa, T. Seki, M. Shimonishi, S. Shimizu, and T. Nakamura Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues Proc. Nat. Acad. Sci. U. S. A. 87 1990 3200 3204
28. E. Van Belle, B. Witzenbichler, D. Chen, M. Silver, L. Chang, R. Schwall, and J.M. Isner Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis Circulation 97 1998 381 390
29. Q. Xu, M. Nakayama, Y. Suzuki, K. Sakai, T. Nakamura, Y. Sakai, and K. Matsumoto Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expression Am. J. Physiol. Gastrointest. Liver Physiol. 302 2012 G420 429
30. Yamabayashi, C., T. Koya, H. Kagamu, H. Kawakami, Y. Kimura, T. Furukawa, T. Sakagami, T. Hasegawa, Y. Sakai, K. Matsumoto, M. Nakayama, E.W. Gelfand, E. Suzuki, I. Narita, 2012. A novel prostacyclin agonist protects to airway hyperresponsiveness and remodeling in mice. Am. J. Respir. Cell. Mol. Biol.
31. Z. Yuan, C. Kishimoto, and K. Shioji Beneficial effects of low-dose benidipine in acute autoimmune myocarditis: suppressive effects on inflammatory cytokines and inducible nitric oxide synthase Circ. J. 67 2003 545 550